The Lancet

A 25-year study in the Lancet found that people over 40 with obesity have comparable blood pressure and cholesterol control to their peers with normal BMI, likely due to increased use of statins and blood pressure medications. The study tracked cardiovascular risk factors during an era of expanded access to these drugs.

A review in The Lancet confirms the safety and effectiveness of mRNA vaccines for COVID-19 and highlights their potential for treating diseases like cancer.

A comprehensive review of mRNA vaccines published in The Lancet confirms their safety and effectiveness, with potential applications beyond Covid-19, including influenza, RSV, and cancer. The study highlights rare serious side effects and emphasizes the technology's adaptability for treating various diseases.

Rep. Ro Khanna dismissed Elon Musk's threats of legal action over criticism of USAID cuts, asserting he would not be intimidated. Musk accused Khanna of lying and suggested suing him, while Khanna cited a Lancet Group study linking the cuts to potential child deaths. The dispute centers on Musk's role in reducing USAID programs during the Trump administration.

Rep. Ro Khanna, a 2028 presidential hopeful, dismissed Elon Musk's threats of legal action after criticizing Musk's role in USAID budget cuts, which Khanna claims may have caused global child deaths. Musk responded by calling Khanna a liar and suggesting legal action, while Khanna expressed confidence in his legal standing.

A study in England found no cervical cancer deaths among women aged 20-24 between 2020-2024, attributed to high HPV vaccination rates (88-90% coverage). In the U.S., RFK Jr.'s vaccine skepticism is slowing HPV vaccination progress.

Obesity has become Brazil's leading health risk, surpassing high blood pressure as the top factor. The data comes from a global disease study published in The Lancet, which attributes the shift to urban lifestyles, reduced physical activity, and processed food consumption.

Ivonescimab, developed by Akeso Therapeutics and Summit Therapeutics, reduced the risk of death by 34% in patients with squamous non-small cell lung cancer compared to standard treatment in a China-based clinical trial. Results were presented at the American Society of Clinical Oncology meeting and published in The Lancet, with Summit’s co-CEO highlighting the drug’s potential business value.

A report in The Lancet warns that the global humanitarian system is failing to address crises in Sudan and Gaza, with hospitals under attack and aid systems overwhelmed. Experts, including Dr. Paul Spiegel of Johns Hopkins University, criticize bureaucratic inefficiencies, the UN's need for reform, and the Trump Administration's restructuring of USAID as contributing to the collapse. The report calls for urgent reforms, including direct aid to communities and accountability for aid blockages.

The name of Polycystic-ovarian syndrome (PCOS) has been changed to polyendocrine metabolic ovarian syndrome (PMOS) due to its inaccuracy in describing the condition. PMOS affects one in eight women and causes a variety of symptoms, including irregular periods and weight gain. The name change aims to reduce delayed diagnosis and stigma.

The article discusses the closure of USAID under President Trump, citing studies predicting millions of deaths globally due to the agency's shutdown. Former leaders and experts criticize the decision, emphasizing USAID's historical impact on global health and development.